SFRS7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.780000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.365800E-01
Normal-vs-Stage2
5.904800E-01
Normal-vs-Stage3
2.110600E-01
Normal-vs-Stage4
8.068200E-01
Stage1-vs-Stage2
6.894800E-01
Stage1-vs-Stage3
1.714400E-01
Stage1-vs-Stage4
1.106340E-02
Stage2-vs-Stage3
6.152200E-02
Stage2-vs-Stage4
1.337920E-02
Stage3-vs-Stage4
6.719500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.962800E-01
Normal-vs-AfricanAmerican
4.781400E-01
Normal-vs-Asian
4.453600E-01
Caucasian-vs-AfricanAmerican
4.416000E-01
Caucasian-vs-Asian
1.695400E-01
AfricanAmerican-vs-Asian
7.499600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.918200E-01
Normal-vs-Female
5.669200E-01
Male-vs-Female
6.798200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.830800E-01
Normal-vs-Age(41-60Yrs)
6.502800E-01
Normal-vs-Age(61-80Yrs)
5.413000E-01
Normal-vs-Age(81-100Yrs)
6.393800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.811000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.450600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.582400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.099590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.045800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.466600E-01
Normal-vs-Daily Drinker
5.164200E-01
Normal-vs-Weekly Drinker
2.942200E-01
Normal-vs-Occasional Drinker
7.172000E-01
Normal-vs-Social Drinker
5.326400E-01
Non Drinker-vs-Daily Drinker
7.716200E-01
Non Drinker-vs-Weekly Drinker
9.782400E-01
Non Drinker-vs-Occasional Drinker
1.572400E-01
Non Drinker-vs-Social Drinker
8.954200E-01
Daily Drinker-vs-Weekly Drinker
7.976400E-01
Daily Drinker-vs-Occasional Drinker
9.166200E-02
Daily Drinker-vs-Social Drinker
8.945400E-01
Weekly Drinker-vs-Occasional Drinker
2.483400E-01
Weekly Drinker-vs-Social Drinker
8.940800E-01
Occasional Drinker-vs-Social Drinker
1.210760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.819000E-01
Normal-vs-Grade 2
5.156600E-01
Normal-vs-Grade 3
5.069800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.546400E-02
Grade 1-vs-Grade 3
3.850100E-02
Grade 1-vs-Grade 4
3.819000E-01
Grade 2-vs-Grade 3
7.812400E-01
Grade 2-vs-Grade 4
5.156600E-01
Grade 3-vs-Grade 4
5.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.679400E-01
Normal-vs-NonDiabetic
5.443200E-01
Diabetic-vs-NonDiabetic
7.594200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.391400E-01
Normal-vs-NoPancreatitis
5.521600E-01
Pancreatitis-vs-NoPancreatitis
8.257800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.854800E-01
Normal-vs-N1
5.896800E-01
N0-vs-N1
9.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.212600E-01
Normal-vs-TP53-NonMutant
9.741800E-02
TP53-Mutant-vs-TP53-NonMutant
2.855800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
